The Latest Cardiac and Vascular News
“Energy First” Protocol Improves Clinical Outcomes SUWANEE, Ga.–(BUSINESS WIRE)–SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced its rebranding. The new brand reflects the evolution of […]
Intuitive, optical-based technology system now available around the world LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta®, the new in-line, blood-gas monitoring system integrated into the market-leading S5® heart-lung machine (HLM). The system is […]
RALEIGH, N.C., April 16, 2021 /PRNewswire/ — Contego Medical, Inc., a leading developer of innovative cardiovascular devices, today announced receipt of CE Mark approval for the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System). The patented Neuroguard IEP System contains a novel, next-generation nitinol stent, a […]
MONMOUTH JUNCTION, N.J., April 19, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader whose flagship E.U. approved CytoSorb® blood purification technology is intended to treat deadly conditions in critically-ill and cardiac surgery patients, announces that the U.S. Food and Drug Administration (FDA) has granted conditional approval of its investigational device exemption (IDE) application for […]
Company Continues to Leverage Data to Strengthen the Istaroxime Patent Estate WARRINGTON, Pa., April 19, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has filed a Track One […]
LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 19, 2021 /PRNewswire/ — Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first […]
TEL AVIV, Israel, April 19, 2021 /PRNewswire/ — Vaica™ Medical, an innovation leading provider in medication adherence and remote patient management (RPM) is announcing its anti-coagulation (blood clotting) remote management solution. The need to maintain an optimal blood viscosity levels is pertinent for at-risk patients with Thrombotic Predisposition (hypercoagulable states), heart rhythm disorders, […]
TEL AVIV, Israel, April 19, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today provided an update of recent corporate developments. Shareholders approved a 1:15 […]
April 19, 2021 New state-of-the-art Central Acute Services Building at Westmead Hospital features next-generation diagnostic and neurovascular imaging solutions, aimed at improving the efficiency and accuracy of care delivered to trauma patients requiring critical care Installation of first Philips Magnetic Resonance – Ingenia MR-OR – intraoperative systems in Australia and […]
VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the journal EuroIntervention has published an article entitled, “Coronary Sinus Reducer Implantation Results in Improved Oxygen Kinetics at Cardiopulmonary Exercise Test in Patients with Refractory Angina.” The article, authored by Carlo Zivelonghi, M.D., Antwerp […]
